TriSalus Life Sciences
TLSI
TLSI
68 hedge funds and large institutions have $198M invested in TriSalus Life Sciences in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $202M → $198M (-$3.98M)
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
Holders
68
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.27M | |
| 2 | +$5.1M | |
| 3 | +$2.12M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$321K |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$247K |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$3.9M | |
| 3 | -$2.32M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.13M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.93M |